Emineon

Industry · Life sciences & MedTech

Regulated product companies write a lot of controlled documentation. We build drafting, review and knowledge systems that respect GxP. People stay accountable, and an inspector can follow the audit trail.

Focus
Adjacent
Value streams
03
Use cases
09
Related services
03

01Context

In life sciences and MedTech, writing often sets the time from data to submission. Clinical and technical documentation, deviations, CAPAs, change controls and regulatory responses. Each must be consistent with hundreds of other controlled documents.

AI can draft, cross-check and retrieve quickly. In a GxP environment this helps only under three conditions. The system is validated for its intended use, changes are controlled, and a qualified person reviews each output. We design to that standard from the start.

313

MedTech, biotech and pharma stakeholders in Geneva.

Source: ge.ch, key sectors

Value streams

  1. 01Regulatory affairs
  2. 02Quality and compliance
  3. 03Scientific knowledge

02Value streams

Each stream is a chain of work we can put agents on, with people deciding where judgement matters.

Submissions and responses drafted from controlled sources.

Use cases

  • 01.1Section drafting for technical files and dossiers from source reports
  • 01.2Health authority question triage and response drafting
  • 01.3Consistency checks across submission documents

03Compliance notes

We design the controls from the first sprint onwards.

  • Computerised system validation approach aligned with GAMP 5 principles for GxP-relevant uses.

  • Change control for models, prompts and retrieval sources. An eval regression triggers revalidation.

  • Qualified-person review and e-signature on each controlled output.

  • Health data and genetic data treated as sensitive personal data under nFADP.

Next step

Tell us about one process that takes your team a lot of time. Happy to have a 30-minute call, no preparation needed.